The Source for Interventional
News and Education
The standard dose is safe and effective in patients with just one of three criteria used to decide who should get a reduced dose, new analysis suggests.
While space travel does carry CV risks, this study is limited by its small sample size and included just three CV deaths, says one expert.
Even among the most high-risk patients, some might be willing to undergo TAVR if it provides meaningful improvements in quality of life, say experts.
Amid talk of TAVR’s “relentless” march to low-risk patients at TVT 2016, experts unveiled the low-risk study designs and offered some notes of caution.